Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function: Safe but no room for complacency
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function : Safe but no room for complacency. / Loh, Poay Huan; Bourantas, Christos V; Chan, Pak Hei; Ihlemann, Nikolaj; Gustafsson, F; Clark, Andrew L; Price, Susanna; Mario, Carlo Di; Moat, Neil; Alamgir, Farqad; Estevez-Loureiro, Rodrigo; Søndergaard, Lars; Franzen, Olaf.
I: World Journal of Cardiology, Bind 7, Nr. 11, 26.11.2015, s. 817-21.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function
T2 - Safe but no room for complacency
AU - Loh, Poay Huan
AU - Bourantas, Christos V
AU - Chan, Pak Hei
AU - Ihlemann, Nikolaj
AU - Gustafsson, F
AU - Clark, Andrew L
AU - Price, Susanna
AU - Mario, Carlo Di
AU - Moat, Neil
AU - Alamgir, Farqad
AU - Estevez-Loureiro, Rodrigo
AU - Søndergaard, Lars
AU - Franzen, Olaf
PY - 2015/11/26
Y1 - 2015/11/26
N2 - Many patients with left ventricular systolic dysfunction have concomitant mitral regurgitation (MR). Their symptoms and prognosis worsen with increasing severity of MR. Percutaneous MitraClip(®) can be used safely to reduce the severity of MR even in patients with advanced heart failure and is associated with improved symptoms, quality of life and exercise tolerance. However, a few patients with very poor left ventricular systolic function may experience significant haemodynamic disturbance in the peri-procedural period. We present three such patients, highlighting some of the potential problems encountered and discuss their possible pathophysiological mechanisms and safety measures.
AB - Many patients with left ventricular systolic dysfunction have concomitant mitral regurgitation (MR). Their symptoms and prognosis worsen with increasing severity of MR. Percutaneous MitraClip(®) can be used safely to reduce the severity of MR even in patients with advanced heart failure and is associated with improved symptoms, quality of life and exercise tolerance. However, a few patients with very poor left ventricular systolic function may experience significant haemodynamic disturbance in the peri-procedural period. We present three such patients, highlighting some of the potential problems encountered and discuss their possible pathophysiological mechanisms and safety measures.
U2 - 10.4330/wjc.v7.i11.817
DO - 10.4330/wjc.v7.i11.817
M3 - Journal article
C2 - 26635930
VL - 7
SP - 817
EP - 821
JO - World Journal of Cardiology
JF - World Journal of Cardiology
SN - 1949-8462
IS - 11
ER -
ID: 162348723